> top > docs > PMC:3586680 > spans > 1623-1829 > annotations

PMC:3586680 / 1623-1829 JSONTXT

Annnotations TAB JSON ListView MergeView

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T2642 205-206 . denotes .
T2641 204-205 -RRB- denotes )
T2640 200-204 CD denotes 2010
T2639 198-199 , denotes ,
T2638 189-198 NNP denotes Nishikawa
T2637 187-188 : denotes ;
T2636 183-187 CD denotes 2000
T2635 181-182 , denotes ,
T2634 178-181 FW denotes al.
T2633 175-177 FW denotes et
T2632 166-174 NNP denotes Friedman
T2631 165-166 -LRB- denotes (
T2630 163-164 -RRB- denotes )
T2629 160-163 NNP denotes TMZ
T2628 159-160 -LRB- denotes (
T2627 146-158 NN denotes temozolomide
T2626 140-145 NN denotes agent
T2625 129-139 NN denotes alkylating
T2624 114-128 JJ denotes monofunctional
T2623 110-113 DT denotes the
T2622 105-109 IN denotes with
T2621 95-104 NN denotes treatment
T2620 91-94 CC denotes and
T2619 89-90 , denotes ,
T2618 80-89 NN denotes radiation
T2617 78-79 , denotes ,
T2616 71-78 NN denotes surgery
T2615 61-70 NN denotes debulking
T2614 53-60 NN denotes maximum
T2613 44-52 VBZ denotes includes
T2612 37-43 RB denotes mainly
T2611 33-36 NNP denotes GBM
T2610 29-32 IN denotes for
T2609 21-28 NN denotes therapy
T2608 12-20 JJ denotes standard
T2607 4-11 JJ denotes current
T2606 0-3 DT denotes The
R1659 T2606 T2609 det The,therapy
R1661 T2607 T2609 amod current,therapy
R1662 T2608 T2609 amod standard,therapy
R1663 T2609 T2613 nsubj therapy,includes
R1665 T2610 T2609 prep for,therapy
R1666 T2611 T2610 pobj GBM,for
R1667 T2612 T2613 advmod mainly,includes
R1669 T2613 T2613 ROOT includes,includes
R1670 T2614 T2616 amod maximum,surgery
R1671 T2615 T2616 compound debulking,surgery
R1673 T2616 T2613 dobj surgery,includes
R1674 T2617 T2616 punct ",",surgery
R1675 T2618 T2616 conj radiation,surgery
R1677 T2619 T2618 punct ",",radiation
R1678 T2620 T2618 cc and,radiation
R1680 T2621 T2618 conj treatment,radiation
R1681 T2622 T2616 prep with,surgery
R1682 T2623 T2626 det the,agent
R1683 T2624 T2626 amod monofunctional,agent
R1685 T2625 T2626 amod alkylating,agent
R1686 T2626 T2627 compound agent,temozolomide
R1687 T2627 T2622 pobj temozolomide,with
R1689 T2628 T2627 punct (,temozolomide
R1690 T2629 T2627 appos TMZ,temozolomide
R1692 T2630 T2627 punct ),temozolomide
R1693 T2631 T2634 punct (,al.
R1694 T2632 T2634 compound Friedman,al.
R1696 T2633 T2634 nmod et,al.
R1697 T2634 T2638 compound al.,Nishikawa
R1699 T2635 T2634 punct ",",al.
R1700 T2636 T2634 dep 2000,al.
R1701 T2637 T2634 punct ;,al.
R1703 T2638 T2616 appos Nishikawa,surgery
R1704 T2639 T2638 punct ",",Nishikawa
R1705 T2640 T2638 npadvmod 2010,Nishikawa
R1706 T2641 T2638 punct ),Nishikawa
R1707 T2642 T2613 punct .,includes

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T2465 110-164 Entity denotes the monofunctional alkylating agent temozolomide (TMZ)
T2400 129-145 Entity denotes alkylating agent
T2391 160-163 Entity denotes TMZ

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T1044 204-205 -RRB- denotes )
T1043 200-204 CD denotes 2010
T1042 198-199 -COMMA- denotes ,
T1041 189-198 NNP denotes Nishikawa
T1040 187-188 -COLON- denotes ;
T1039 183-187 CD denotes 2000
T1038 181-182 -COMMA- denotes ,
T1037 178-181 FW denotes al.
T1036 175-177 FW denotes et
T1035 166-174 NNP denotes Friedman
T1034 165-166 -LRB- denotes (
T1033 163-164 -RRB- denotes )
T1032 160-163 NN denotes TMZ
T1031 159-160 -LRB- denotes (
T1030 146-158 NN denotes temozolomide
T1029 140-145 NN denotes agent
T1028 129-139 VB denotes alkylating
T1027 114-128 JJ denotes monofunctional
T1026 110-113 DT denotes the
T1025 105-109 IN denotes with
T1024 95-104 NN denotes treatment
T1023 91-94 CC denotes and
T1022 89-90 -COMMA- denotes ,
T1021 80-89 NN denotes radiation
T1020 78-79 -COMMA- denotes ,
T1019 71-78 NN denotes surgery
T1018 61-70 VB denotes debulking
T1017 53-60 JJ denotes maximum
T1016 44-52 VB denotes includes
T1015 37-43 RB denotes mainly
T1014 33-36 NN denotes GBM
T1013 29-32 IN denotes for
T1012 21-28 NN denotes therapy
T1011 12-20 JJ denotes standard
T1010 4-11 JJ denotes current
T1009 0-3 DT denotes The
R567 T1012 T1009 arg1Of therapy,The
R572 T1019 T1020 arg1Of surgery,","
R573 T1020 T1023 arg1Of ",",and
R574 T1021 T1020 arg2Of radiation,","
R575 T1023 T1016 arg2Of and,includes
R576 T1023 T1022 arg1Of and,","
R577 T1024 T1023 arg2Of treatment,and
R578 T1024 T1025 arg1Of treatment,with
R579 T1030 T1025 arg2Of temozolomide,with
R580 T1030 T1026 arg1Of temozolomide,the
R581 T1030 T1027 arg1Of temozolomide,monofunctional
R582 T1030 T1028 arg1Of temozolomide,alkylating
R583 T1030 T1029 arg1Of temozolomide,agent
R584 T1030 T1031 arg1Of temozolomide,(
R585 T1030 T1034 arg1Of temozolomide,(
R586 T1032 T1031 arg2Of TMZ,(
R587 T1033 T1031 arg3Of ),(
R588 T1035 T1034 arg2Of Friedman,(
R589 T1035 T1036 arg1Of Friedman,et
R590 T1035 T1037 arg1Of Friedman,al.
R591 T1035 T1038 arg1Of Friedman,","
R592 T1035 T1040 arg1Of Friedman,;
R593 T1039 T1038 arg2Of 2000,","
R594 T1041 T1040 arg2Of Nishikawa,;
R595 T1041 T1042 arg1Of Nishikawa,","
R596 T1043 T1042 arg2Of 2010,","
R597 T1044 T1034 arg3Of ),(
R563 T1012 T1010 arg1Of therapy,current
R564 T1012 T1011 arg1Of therapy,standard
R565 T1012 T1013 arg1Of therapy,for
R566 T1012 T1016 arg1Of therapy,includes
R568 T1014 T1013 arg2Of GBM,for
R569 T1016 T1015 arg1Of includes,mainly
R570 T1019 T1017 arg1Of surgery,maximum
R571 T1019 T1018 arg1Of surgery,debulking

2_test

Id Subject Object Predicate Lexical cue
23459853-10914698-38778484 183-187 10914698 denotes 2000
23459853-20885105-38778485 200-204 20885105 denotes 2010

sentences

Id Subject Object Predicate Lexical cue
T878 0-206 Sentence denotes The current standard therapy for GBM mainly includes maximum debulking surgery, radiation, and treatment with the monofunctional alkylating agent temozolomide (TMZ) (Friedman et al., 2000; Nishikawa, 2010).
T14 0-206 Sentence denotes The current standard therapy for GBM mainly includes maximum debulking surgery, radiation, and treatment with the monofunctional alkylating agent temozolomide (TMZ) (Friedman et al., 2000; Nishikawa, 2010).